Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study

• Yuki Kohada,
• Hiroki Kusumoto,
• Takashi Kukimoto,
• Jotaro Mikami,
• Jun Ito,
• Katsutoshi Asano,
• Toru Yaegashi,
• Kanichi Nakagawara,
• Jun Teishima,
• Yasuhiro Kaiho,
• Nobuyuki Hinata,
• Yasuhiro Nakamura,
• Makoto Sato

Affiliations

Yuki Kohada

Corresponding author. Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.; Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

Hiroki Kusumoto

Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Takashi Kukimoto

Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Jotaro Mikami

Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Jun Ito

Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Katsutoshi Asano

Nihon Gene Research Laboratories Inc, Sendai, Japan

Toru Yaegashi

Nihon Gene Research Laboratories Inc, Sendai, Japan

Kanichi Nakagawara

Nihon Gene Research Laboratories Inc, Sendai, Japan

Jun Teishima

Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

Yasuhiro Kaiho

Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Nobuyuki Hinata

Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

Yasuhiro Nakamura

Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Makoto Sato

Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan